1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information on the Company’s share repurchases during the second quarter of fiscal 2026:
+Added: The following table provides information on the Company’s share repurchases during the third quarter of fiscal 2026:
Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Program Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (1)(2)
(Dollars in Thousands, Except Per Share Data)
−Removed: June 29, 2025 – July 26, 2025 — — — $ 500,000
−Removed: July 27, 2025 – August 23, 2025 1,113,586 $ 53.88 1,113,586 $ 425,000
−Removed: August 24, 2025 – September 27, 2025 316,993 $ 47.32 316,993 $ 425,000
−Removed: Total 1,430,579 1,430,579
+Added: September 28, 2025 – October 25, 2025 — — — $ 425,000
+Added: October 26, 2025 – November 22, 2025 — — — $ 425,000
+Added: November 23, 2025 – December 27, 2025 — — — $ 425,000
(1) In April 2025, our Board approved a three-year share repurchase program authorizing the repurchase of up to $500.0 million of Haemonetics common stock, based on market conditions, through April 2028.
2 unchanged sentences
The total number of shares repurchased under the ASR was 1,430,579 at an average price per share upon final settlement of $52.43.
−Removed: As of September 27, 2025, the total remaining authorization for repurchases of our common stock under the share repurchase program was $425.0 million.
+Added: As of December 27, 2025, the total remaining authorization for repurchases of our common stock under the share repurchase program was $425.0 million.
Defaults Upon Senior Securities
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.